Literature DB >> 22219777

Bis(7-amino-1,2,4-triazolo[1,5-a]pyrimidin-4-ium) bis-(oxalato-κO,O)cuprate(II) dihydrate.

Ana B Caballero, Oscar Castillo, Antonio Rodríguez-Diéguez, Juan M Salas.   

Abstract

The structure of the title ionic compound, (C(5)H(6)N(5))(2)[Cu(C(2)O(4))(2)]·2H(2)O, consists of a centrosymmetric copper(II) oxalate dianion, two monoprotonated mol-ecules of the adenine analog 7-amino-1,2,4-triazolo[1,5-a]pyrimidine (7atp) and two water mol-ecules of crystallization. The Cu(II) ion, located on an inversion center, exhibits a sligthly distorted square-planar coordination geometry, in which two oxalate anions bind in a bidentate fashion. The triazolopyrimidine ligand is protonated at the N atom in position 4, instead of its most basic N atom in position 3. This fact may be explained by the network stability, which is provided through the formation of a two-dimensional wave-like network parallel to (50[Formula: see text]) by N-H⋯O, O-H⋯N and O-H⋯O hydrogen bonds. These nets are further connected via C-H⋯O inter-actions.

Entities:  

Year:  2011        PMID: 22219777      PMCID: PMC3246957          DOI: 10.1107/S1600536811040724

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


  4 in total

1.  Dinuclear silver(I) complexes for the design of metal-ligand networks based on triazolopyrimidines.

Authors:  Ana B Caballero; Jana K Maclaren; Antonio Rodríguez-Diéguez; Isaac Vidal; Jose A Dobado; Juan M Salas; Christoph Janiak
Journal:  Dalton Trans       Date:  2011-10-05       Impact factor: 4.390

Review 2.  Supramolecular DNA recognition.

Authors:  Michael J Hannon
Journal:  Chem Soc Rev       Date:  2006-11-17       Impact factor: 54.564

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 4.  The purines: potent and versatile small molecule inhibitors and modulators of key biological targets.

Authors:  Michel Legraverend; David S Grierson
Journal:  Bioorg Med Chem       Date:  2006-02-24       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.